Inotuzumab-ozogamicin/BlinatumomabNo response: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2021年 / 1864卷 / 1期
关键词：
D O I：
10.1007/s40278-021-99125-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：195 / 195
相关论文
共 50 条
  • [31] Inotuzumab ozogamicinAcute cholecystitis: case report
    Reactions Weekly, 2018, 1695 (1) : 221 - 221
  • [32] Inotuzumab-ozogamicinHepatotoxicity: case report
    Reactions Weekly, 2023, 1971 (1) : 138 - 138
  • [33] The Effectiveness of Inotuzumab Ozogamicin in a Case with Refractory CD22 Positive Acute Undifferentiated Leukemia Case
    Nakamura, Nao
    Kato, Itaru
    Akazawa, Ryo
    Masuno, Hiroaki
    Shiota, Mitsutaka
    Saida, Satoshi
    Umeda, Katsutsugu
    Hiramatsu, Hidefumi
    Adachi, Souichi
    Takita, Junko
    PEDIATRIC BLOOD & CANCER, 2020, 67
  • [34] EBFI Activity Controls Leukemia Sensitivity to Inotuzumab Ozogamicin
    Escherich, Carolin S.
    Li, Zhenhua
    Barnett, Kelly R.
    Li, Yizhen
    Walker, Megan
    Yang, Wenjian
    Huang, Xin
    Yu, Jiyang
    Stock, Wendy
    Paietta, Elisabeth
    Konopleva, Marina
    Kornblau, Steven M.
    Litzow, Mark R.
    Inaba, Hiroto
    Pui, Ching-Hon
    Loh, Mignon L.
    Savic, Daniel
    Yang, Jun J.
    BLOOD, 2024, 144 : 830 - 831
  • [35] Inotuzumab ozogamicin for the treatment of patients with acute lymphocytic leukemia
    Choudhry, A.
    O'Brien, S. M.
    DRUGS OF TODAY, 2017, 53 (12) : 653 - 665
  • [36] Successful diagnosis of veno-occlusive disease caused by inotuzumab ozogamicin through minimal-invasive angiography: a case report
    Sato, Michiaki
    Yasunaga, Megumi
    Ohzu, Masami
    Toyama, Kazuhiro
    Nakazaki, Kumi
    Nakahara, Fumio
    Kubo, Takatoshi
    Okura, Naoki
    Abe, Osamu
    Kurokawa, Mineo
    ANNALS OF HEMATOLOGY, 2022, 101 (05) : 1153 - 1155
  • [37] Successful diagnosis of veno-occlusive disease caused by inotuzumab ozogamicin through minimal-invasive angiography: a case report
    Michiaki Sato
    Megumi Yasunaga
    Masami Ohzu
    Kazuhiro Toyama
    Kumi Nakazaki
    Fumio Nakahara
    Takatoshi Kubo
    Naoki Okura
    Osamu Abe
    Mineo Kurokawa
    Annals of Hematology, 2022, 101 : 1153 - 1155
  • [38] Evaluation of the efficacy of ursodiol for prevention of hepatotoxicity in patients receiving gemtuzumab ozogamicin and inotuzumab ozogamicin
    Sabatino, David
    Henneman, Amrita
    Ahmad, Samrah
    Jou, Erin
    Goldberg, Bradley
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (04) : 840 - 845
  • [39] Treatment of adult acute lymphoblastic leukemia with inotuzumab ozogamicin
    Paul, Shilpa
    Rausch, Caitlin R.
    Kantarjian, Hagop
    Jabbour, Elias J.
    FUTURE ONCOLOGY, 2017, 13 (25) : 2233 - 2242
  • [40] A patient with refractory high-grade B-cell lymphoma and rapid progression under CAR-T-cell therapy was successfully salvaged with inotuzumab-ozogamicin
    Struessmann, T.
    Waesch, R.
    Scherer, F.
    Mutter, J. A.
    Pfeifer, D.
    Bartsch, I.
    Giesler, S.
    Graziani, G.
    Duyster, J.
    Finke, J.
    Marks, R.
    LEUKEMIA & LYMPHOMA, 2022, 63 (09) : 2260 - 2262
12345